Back to search

Article

Identification of SNHG16 and Its Derived Tumor Immune Gene Signatures for Predicting Prognosis and Efficacy of Immunotherapy in Bladder Cancer

2022-10-24

Abstract excerpt

<h4>Background: </h4> In the era of individualized therapy,there is a great need to incorporate lncRNAs into preclinical models to develop prognostic or therapeutic biomarkers.We sought to apply the tumor immune-associated lncRNA – SNHG16 to develop and validate a predictive model constructed from SNHG16 and associated immune gene signatures in BC patients obtained from independent public datasets and clinical int...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
68eac6e8-5fa2-5ff5-9898-c44b2752f495
DOI
10.21203/rs.3.rs-2118651/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification of SNHG16 and Its Derived Tumor Immune Gene Signatures for Predicting Prognosis and Efficacy of Immunotherapy in Bladder CancerDOI 10.21203/rs.3.rs-2118651/v1
Integrative analysis of immune molecular subtypes and microenvironment characteristics of bladder cancer.Semantic proximity
Identification of subgroups of bladder cancer based on immune gene signatureSemantic proximity
The Immunogenomic Landscape of and Immune Cell Infiltration in Bladder CancerSemantic proximity
Prognostic Value of Interferon-γ-Related Signature Involved in Tumor Immune Infiltration in Bladder CancerSemantic proximity
Targeting Macrophage-Associated Core Genes for Prognostic Prediction and Therapeutic Insights in Bladder CancerSemantic proximity
An IFN-γ-related signature predicts prognosis and immunotherapy response in bladder cancer: Results from real-world cohortsSemantic proximity
Risk stratification based on immune signature and prediction of immune checkpoint inhibitor’s efficacy for bladder urothelial carcinomaSemantic proximity
Bioinformatics Analysis Finds Immune Gene Markers Related to the Prognosis of Bladder CancerSemantic proximity
Identification of hypoxia- and immune- based prognostic signature and validation of TFRC as a potential biomarker and therapeutic target in BLCASemantic proximity
Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancerSemantic proximity
Development of A Prognostic Index and Screening of Prognosis Related Genes Based on an Immunogenomic Landscape Analysis of Bladder CancerSemantic proximity
New exploration of bladder cancer-related immune gene biomarkers in predicting the prognosis of urinary system tumorsSemantic proximity
Select a neighboring publication to make it the new centre.